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We developed a two-week-old murine model for human
Enterovirus 71 encephalomyelitis to study pathological
changes and viral spread into and within the central nerv-
ous system (CNS). Mice infected via oral and parenteral
routes with a murine-adapted virus strain originally iso-
lated from a fatal human case, succumbed to infection
after 2–5 days. Degenerate or normal appearing CNS neu-
rons showed evidence of viral RNA, antigens and virions
as demonstrated by in situ hybridization, immunohisto-
chemistry and electron microscopy, respectively. The
most severely infected neurons were in anterior horns,
motor trigeminal nuclei and brainstem reticular forma-
tion. Fewer neurons in the red, lateral cerebellum and
other cranial nerve nuclei, motor cortex, hypothalamus
and thalamus were infected. The cerebellar hemisphere,
sensory cortex, and dorsal root or autonomic ganglia were
spared. Although inflammation was minimal or insignifi-
cant, this stereotyped distribution of virus in the mouse
CNS, which was more or less similar for all routes, resem-
bled the distribution of inflammation and virus in human
encephalomyelitis. In a separate experiment, intramuscu-
lar-inoculated mice sacrificed over 24 to 36 h post infec-
tion timepoints showed increasing viral RNA/antigens in
the ipsilateral lumbar anterior horn and adjacent efferent
motor axons. From 48–72 h, motor neurons in upper
cord segments, brainstem and contralateral motor cortex
became infected. Viral culture from the spinal cord cor-
roborated these findings. The data support the notion that
for all inoculation routes, viral entry into the CNS was by
peripheral motor nerves whereas spread within the CNS
could involve motor and other neural pathways. Viral
RNA/antigens were also detected early in skeletal muscle
and brown adipose tissues but not in lymph node, thy-
mus, spleen, Peyer's patches, heart, lung and gastrointesti-
nal tissues. We hypothesize that the primary viral
replication sites were skeletal muscles and adipose tissues,
and that following skeletal muscle infection, virus entered
motor nerves to travel up to the CNS. Genomic sequence
analysis of the adapted and parental (non-neurovirulent)
viral strains revealed 7 nucleotide differences including 2
each in the VP2 and VP1 regions, and 1 each in the 5'NTR,
2A and 3A regions. The corresponding deduced amino
acid sequence changes could contribute to neuroviru-
lence. With better pathological characterization, espe-
cially of the CNS, this model should be useful for further
neuropathogenesis studies and anti-viral agent/vaccine
testing.
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